Drug companies sometimes fail to adequately warn expectant mothers that certain drugs increase the chance of birth defects. According to the U.S. Food and Drug Administration (FDA), one of the most popular anti-nausea drugs on the market increases the risk that children will be born with birth defects and birth injuries. Zofran®, manufactured by GlaxoSmithKline, is commonly prescribed by doctors to reduce nausea in pregnant women, even though the drug has not been approved to treat morning sickness. Prescribing Zofran® to pregnant women is an off-label use of the common prescription drug.
You and your family rely on your medication and your doctor to keep you safe. We created the Zofran® Birth Defect guide to help parents understand birth defects associated with Zofran®:
- Kidney failure
- Heart defects and heart murmurs
- Cleft lip and cleft palate
- Organ malformation or malpositioning
The attorneys at Cory Watson have represented families harmed by the negligence and wrongful conduct of others for more than 30 years, and our lawyers are currently representing women and children harmed by Zofran and other drugs. Call (877) 526-0000 or complete a free initial consultation form to learn more about how our experienced attorneys can help.
Zofran® is a registered trademark of Glaxo Group Limited Corporation and is used here only to identify the product in question.
This law firm is not affiliated with, sponsored by, or associated with Glaxo Group Limited Corporation or the U.S. Food and Drug Administration.